To include your compound in the COVID-19 Resource Center, submit it here.

Cancer

INDICATION: Chronic myelogenous leukemia (CML); acute myelogenous leukemia (AML)

Cell culture and mouse studies suggest inhibiting protein PML

Read the full 171 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE